Merck & Co., Inc. is a global research-driven pharmaceutical products company. Committed to bringing out the best in medicine
Contact usWorldwide
HomeAbout MerckProductsNewsroomInvestor InformationCareersResearchLicensingThe Merck Manuals

The Merck Manual--Second Home Edition logo
 
click here to go to the Index click here to go to the Table of Contents click here to go to the search page click here for purchasing information
Chapter 146. Tubular and Cystic Kidney Disorders
Topics: Introduction | Renal Tubular Acidosis | Renal Glucosuria | Nephrogenic Diabetes Insipidus | Cystinuria | Fanconi's Syndrome | Hypophosphatemic Rickets | Hartnup Disease | Bartter's Syndrome | Liddle's Syndrome | Polycystic Kidney Disease | Medullary Cystic Disease | Medullary Sponge Kidney | Alport's Syndrome | Nail-Patella Syndrome
 
green line

Liddle's Syndrome

Liddle's syndrome is a rare hereditary disorder in which the kidneys excrete potassium but retain too much sodium and water, leading to high blood pressure.

The gene that causes Liddle's syndrome is dominant, meaning that children of a person with the disorder have a 50% chance of inheriting the defective gene. The disorder does not always cause symptoms. When it does, symptoms such as high blood pressure often begin during childhood.

The condition is effectively treated by drugs that increase sodium excretion and lessen potassium excretion, such as triamterene or amiloride. These drugs effectively lower the blood pressure. The prognosis is very good.

Site MapPrivacy PolicyTerms of UseCopyright 1995-2004 Merck & Co., Inc.